World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03213223
Date of registration: 30/06/2017
Prospective Registration: No
Primary sponsor: University of Zimbabwe
Public title: Retention of Women in the PMTCT (Prevention of Mother-to-child Transmission of HIV)
Scientific title: Retention-in-care of Women in the Elimination of Mother-to-child Transmission of HIV (eMTCT) Option B Plus Program in Mashonaland East, Zimbabwe: a Mixed Method Study
Date of first enrolment: November 18, 2016
Target sample size: 468
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03213223
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Zimbabwe
Contacts
Name:     Augustine Ndaimani, DPhil MD (Student)
Address: 
Telephone:
Email:
Affiliation:  University of Zimbabwe
Key inclusion & exclusion criteria

Inclusion Criteria:

- women 15-49 years. On PMTCT tes and treat strategy or Option B+

Exclusion Criteria:

- mentally unstable women or not enrolled at the study sites for PMTCT. Women enrolled
in Option B Censoring - after a miscarriage, still birth, on leaving the PMTCT program
and at the end of the study



Age minimum: 15 Years
Age maximum: 49 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Prevention of Mother-to-child Transmission of HIV
Intervention(s)
Primary Outcome(s)
Retention in care based on record review and follow up data [Time Frame: One follow-up per 3-month period, up to 12 months]
Attrition from PMTCT (determined through survival analysis based on Cox proportional hazards regression) [Time Frame: One follow-up per 3-month period, up to 12 months]
Secondary Outcome(s)
Barriers and enablers of retention (focus group discussions) [Time Frame: One focus group per week, up to 4 weeks, (total of four focus group discussions)]
Secondary ID(s)
A2087
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
NORHED
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history